<DOC>
	<DOCNO>NCT01999348</DOCNO>
	<brief_summary>The study evaluate patient diagnose POAG OHT switch GANFORT® UD ( unit dose fix combination bimatoprost timolol ) therapy medical reason accordance physician standard clinical practice . All treatment decision lie physician .</brief_summary>
	<brief_title>A Study GANFORT® UD Patients With Primary Open Angle Glaucoma ( POAG ) Ocular Hypertension ( OHT ) Medical Setting</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<criteria>Diagnosed primary openangle glaucoma ocular hypertension Previously prescribe intraocular pressure ( IOP ) lower medication insufficient IOP control switch GANFORT® UD medical reason</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>